MoneyWorks4Me

Hikal - Quaterly Results

02 Nov 2023 Evaluate
Net sales declined -22.17%  to  Rs. 4348.80 million from Rs. 5587.50 millions.A big decline of -49.60% was reported for the quarter ended September 2023 to Rs. 125.20  millions from Rs. 248.40 millions of corresponding previous quarter.A decline of 584.60 millions was observed in the OP in the quarter ended September 2023 from 709.80 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 4348.80 5587.50 -22.17 8229.30 9375.40 -12.22 20230.30 19427.20 4.13
Other Income 9.90 12.50 -20.80 19.30 45.20 -57.30 54.10 48.90 10.63
PBIDT 584.60 709.80 -17.64 1096.30 969.20 13.11 2624.70 3454.50 -24.02
Interest 130.80 108.00 21.11 268.70 220.90 21.64 481.00 312.10 54.12
PBDT 453.80 601.80 -24.59 827.60 748.30 10.60 2143.70 3142.40 -31.78
Depreciation 285.70 274.10 4.23 563.00 539.10 4.43 1090.10 956.70 13.94
PBT 168.10 327.70 -48.70 264.60 209.20 26.48 1053.60 2185.70 -51.80
TAX 42.90 79.30 -45.90 70.80 50.20 41.04 269.80 580.60 -53.53
Deferred Tax -2.10 25.80 -108.14 -1.40 -3.30 -57.58 -35.00 -15.90 120.13
PAT 125.20 248.40 -49.60 193.80 159.00 21.89 783.80 1605.10 -51.17
Equity 246.60 246.60 0.00 246.60 246.60 0.00 246.60 246.60 0.00
PBIDTM(%) 13.44 12.70 5.82 13.32 10.34 28.87 12.97 17.78 -27.04
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..